Camilla Falivena

Rognoni, Carla; Falivena, Camilla; Costa, Francesco; Armeni, Patrizio (2023). Cost-utility analysis of esketamine for patients with treatment resistant depression in Italy. PHARMACOECONOMICS, vol. 41, 2, p.209 - 225 , DOI: 10.1007/s40273-022-01220-z

Brunelli, Sandro; Murzakhmetova, Anel; Falivena, Camilla (2022). Environmental auditing in rural areas: current patterns and future challenges in Central Asia. SUSTAINABILITY, vol. 14, 22, p.15163 - - , DOI: 10.3390/su142215163

Brunelli, Sandro; Falivena, Camilla; Carlino, Chiara; Venuti, Francesco (2021). Accountability for climate change: a research synthesis through the lenses of the integrated thinking approach. MEDITARI ACCOUNTANCY RESEARCH, vol. 29, 4, p.1005 - 1038 , DOI: 10.1108/MEDAR-01-2020-0682

Brunelli, Sandro; Falivena, Camilla; Anselmi, Luca (2020). Applicazione e potenziamento del PIP (Pandemic Influenza Preparedness Framework) in ambito OMS: un'arma in più per affrontare le fasi successive al picco da Covid-19. MECOSAN, 113, p.9 - 15 , DOI: 10.3280/MESA2020-113002

D'Amato, Antonio; Falivena, Camilla (2020). Corporate social responsibility and firm value: do firm size and age matter? Empirical evidence from European listed companies. CORPORATE SOCIAL RESPONSIBILITY AND ENVIRONMENTAL MANAGEMENT, vol. 27, 2, p.909 - 924 , DOI: 10.1002/csr.1855

Stegbauer, Constance; Falivena, Camilla; Moreno, Ariadna; Hentschel, Anna; Rosenmöller, Magda; Heise, Tim; Szecsenyi, Joachim; Schliess, Freimut (2020). Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies. BMC HEALTH SERVICES RESEARCH, vol. 20, 1, p.1043 - - , DOI: 10.1186/s12913-020-05897-w